Triptan use and risk of cardiovascular events: a nested-case-control study from the French health system database - Lugardon, S.; Roussel, H.; Sciortino, V.; Montastruc, J. L.; Lapeyre-Mestre, M. (European journal of clinical pharmacology, 2007)
Keywords: Adult; Atherosclerosis (general aspects, experimental research); Biological and medical sciences; Blood and lymphatic vessels; Cardiology. Vascular system; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - chemically induced; Cardiovascular Diseases - epidemiology; Cardiovascular system; Case-Control Studies; Cohort Studies; Databases, Factual; Drug therapy; Drug Utilization - statistics & numerical data; Female; France - epidemiology; Headache; Health care; Heart; Humans; Ischemia; Male; Medical sciences; Middle Aged; Migraine; Migraine Disorders - drug therapy; Patients; Pharmacology; Pharmacology. Drug treatments; Risk; Risk factors; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists - adverse effects; Serotonin Receptor Agonists - therapeutic use; Side effects; Tryptamines - adverse effects; Tryptamines - therapeutic use; France; Europe; Vascular disease; Human; Health system; Overuse·Triptans; Ischemia; Atherosclerosis; Cardiovascular risk; Database; Triptan derivatives; Cardiovascular events Ischemic event; Cardiovascular disease; Case control study